Cannabis Law Report

DECEMBER 3, 2021

We look forward to sharing clinical trial data supporting the potential of ganaxolone to treat a range of seizure disorders as well as research data highlighting the impact that seizures can have on developmental progressions and quality of life in children with CDD.”. Ganaxolone was generally well tolerated with no new safety findings.

Epilepsy 40

Epilepsy Pharmaceutical Data Clinical Trials 40

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

CannaMD

AUGUST 19, 2020

Researchers with Microbiology and Molecular Biology Reviews elaborate: The term “cytokine storm” calls up vivid images of an immune system gone awry and an inflammatory response flaring out of control. ” And their alternative strategy of choice? SARS-CoV2 is the virus that causes COVID-19.). Terpenes and CBD: Twice as Effective.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 40

Epilepsy Clinical Trials Research and Development Pharmaceutical 40

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

The Cannigma

JUNE 29, 2021

Though the distinction between these terms may seem trivial at first glance, it is in fact crucial for cannabis research, and therefore also for consumers and regulators as well. Researchers conducting survey based studies today often only have access to the THC concentration of the cannabis that their participants are using.

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Effective, most effective in treatment Relieve symptoms.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome.

Safety 52

Safety Cannabinoids Events Data 52

Canna Law Blog

JUNE 18, 2019

Second, the Committee focused on the safety of CBD itself. FDA-approved Epidiolex , the epilepsy medication that contains CBD, includes a warning about liver damage. The FDA must also preserve incentives to research CBD’s health benefits. That being said, the Committee also wants CBD in drugs.

Hemp 95

Hemp CBD Food Research and Development 95

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 119

Research and Development Education Agriculture Patients 119

Veriheal

JANUARY 18, 2023

The lack of regulation has raised concerns about consumer safety. Research commissioned by the Centre for Medicinal Cannabis pinned a £1 billion valuation on the CBD market by the year 2025. This rare type of epilepsy caused her to endure up to 300 grand mal seizures per week from the tender age of five. Home Office.

CBD 97

CBD Strains Research and Development Oil 97

MMJ Recs

NOVEMBER 17, 2023

Licensing fees, taxes, and other revenue sources associated with MMJ operations generate income that can be reinvested in public services, healthcare initiatives, and community development. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JANUARY 18, 2022

Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders, and anti-viral indications, reported positive results of four preclinical dermal safety studies for Epoladerm™ (diclofenac epolamine). Mack, Chairman and CEO of Virpax. Christopher M.

Safety 40

Safety Chronic Pain Research and Development Pharmaceutical 40

Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. –(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc.

Research and Development 40

Research and Development Chronic Pain Pharmaceutical Clinical Trials 40

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Thanks to their diligence in perfecting the drug and ensuring its safety for intended use, the Drug Enforcement Agency scheduled Epidiolex under the lowest Schedule classification for controlled substances. Dravet Syndrome.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Veriheal

JUNE 22, 2020

This approval came after significant research into the effects of cannabis on seizure disorders. The priority was ensuring the health and safety of the baby. However, the future’s looking bright—both for Oscar Parodi and for any number of future newborns who may benefit from the treatments being developed.

Therapy 76

Therapy Treatment Research and Development Conditions 76

The Cannigma

JANUARY 16, 2023

1 Muscimol is a well-researched, natural compound and has been studied as a potential treatment for drug-resistant epilepsy, its potential effects on neurological disorders, and its pain-relieving abilities. Muscimol was the molecule used by scientists to develop numerous new pharmaceutical drugs aimed at targeting the GABA system.

Research and Development 127

Research and Development History Treatment Retail 127

The Joint Blog

JANUARY 12, 2020

However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. You’d be astounded by the analysis we’ve seen of products on the shelf with virtually no CBD in them,” said Cornell University veterinary researcher Joseph Wakshlag: He studies therapeutic uses for the compound.

Pets 36

Pets CBD Clinical Trials Research and Development 36

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. The stigma is largely due to its association with recreational use and misconceptions about its effects.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Cannabis Law Report

MARCH 6, 2020

“Kannalife’s research has the potential to make a global impact as their growing portfolio of international patents pushes forward their go-to-market strategy.” It’s safety and efficacy have not been confirmed by FDA-approved research. This is the sixth patent grant that Kannalife has received.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

Cannabis Law Report

NOVEMBER 24, 2019

Recommendations for research. Severe treatment-resistant epilepsy. 1.4 Severe treatment-resistant epilepsy. NICE has made research recommendations on the use of cannabis-based medicinal products for severe treatment-resistant epilepsy. potential impact on structural and functional brain development.

Medicine 59

Medicine Chronic Pain Research and Development Treatment 59

Otherside Farms

NOVEMBER 10, 2019

Autism cannot be described as a single disease but includes the entire spectrum of conditions that affect healthy mental development. Disorders of neural development manifest in them as the inability of normal communication, the absence of empathy, attention disorder, and other intellectual disabilities. Safety of Use.

Therapy 56

Therapy Research and Development Epilepsy CBD 56

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

WeedAdvisor

APRIL 1, 2019

CBD Oil for dogs, cats and other pets is a natural development of the cannabidiol (CBD) craze. As anecdotal evidence began piling up, some companies decided that CBD’s reported effects on epilepsy (which has been heavily proven), anxiety, insomnia, pain and inflammation – among others – could work on dogs, cats and other pets.

Pets 49

Pets Oil CBD Research and Development 49

MMJ Recs

JULY 5, 2024

Understanding THC’s mechanisms and clinical implications is crucial as researchers continue to uncover its therapeutic potential and limitations in medical settings. Neurological Disorders Research suggests THC may benefit neurological conditions such as epilepsy, multiple sclerosis (MS), and Parkinson’s disease.

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

Cannabis Law Report

MARCH 9, 2020

Food and food additives imported into China must have Chinese labeling and requirements under the Food Safety Act, i.e. they must be approved for import. Israel is the world leader in research and development on CBD oil but strictly controls the cannabinoid. Status: Legal Grey Area (Legal Lean). Status: Banned. Status : Banned.

Oil 64

Oil CBD Legalization Research and Development 64

United Patients Group

JULY 29, 2024

Research has also shown that cannabis contains terpenes , aromatic compounds that contribute to its therapeutic effects. Understanding the synergy between these elements is crucial for developing a holistic approach to health. It is also vital to consider dosage and delivery methods to ensure optimal results.

Research and Development 52

Research and Development Strains Chronic Pain Medicine 52

Cannabis Law Report

JANUARY 26, 2022

The Innovation Passport does not reduce the burden of demonstrating that a treatment may be safe and effective, but does provide research organizers with expert advice, patient input, and collaboration throughout the clinical trial design and development process through a product-specific Target Development Profile. ABOUT MAPS.

Therapy 52

Therapy Clinical Trials Research and Development Treatment 52

Alchimia

FEBRUARY 1, 2022

Recent scientific studies have proven that cannabidiol contains the following therapeutic properties: Anticonvulsant : especially suitable to treat Dravet syndrome, a very aggressive type of childhood epilepsy. Neuroprotective : could contribute to the treatment of neurodegenerative diseases such as multiple sclerosis. Drowsiness.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

The Cannigma

MARCH 12, 2021

And in my belief, it should be cannabis, because of the safety profile, number one. So, if the cultivators could develop a relationship with their customers, they could get a lot more brand loyalty and that would create much more stability. RF: That’s absolutely the case. That’s becoming more and more ubiquitous.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

MARCH 2, 2020

The government said it is working with industry to explore further ways to reduce costs and encourage more research into uninterrupted access to cannabis-based medicinal products where clinically appropriate. The event will bring together cannabinoid researchers from around the world and representatives from NIHR, NICE, and the DHSC.

Medicine 45

Medicine Research and Development Clinical Trials Patients 45

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

MMJ Recs

JUNE 9, 2024

Qualifying conditions include chronic or debilitating diseases, including cancer, epilepsy, multiple sclerosis, Crohn’s disease, Parkinson’s disease, and post-traumatic stress disorder (PTSD), among others.

Access 52

Access Marijuana Patients Programs 52

The Joint Blog

MARCH 21, 2021

There is evidence out there to suggest that CBD oil can be used to treat the following conditions: Epilepsy. So does the research support this? CBD Safety. Depression. Chronic pain. Cancer-related symptoms. Is CBD oil legal? Easy things to look out for include: Clear labelling with details of CBD quantity.

Safety 26

Safety CBD Oil Cannabinoids 26

Cannabis Law Report

JULY 13, 2019

The report goes on to say it believes more research is needed into cannabis prescriptions in the U.K. But it says one of the barriers to research is that industry is not always prepared to supply products for research trials. However the problem in the U.K. is such special drugs are subject to stringent guidelines.

Research and Development 40

Research and Development Clinical Trials Epilepsy Patients 40